251 studies found for:    Cerebral Atrophy
Show Display Options
Download search resultsDownload the search results for:
Cerebral Atrophy (251 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed
Has Results
A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
2 Completed Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease
Conditions: Alzheimer's Disease;   Posterior Cortical Atrophy;   Logopenic Progressive Aphasia
3 Recruiting Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer Acetate
Condition: Multiple Sclerosis
4 Recruiting Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)?
Condition: Multiple Sclerosis
5 Active, not recruiting Sunphenon in Progressive Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Sunphenon EGCG;   Drug: Placebo
6 Completed Focal Cortical Atrophy After Myocardial Internal Capsule
Condition: Ischemic Stroke Involving Corticospinal Tract.
Intervention: Other: Additional MRI
7 Completed A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years
Condition: Multiple Sclerosis
8 Completed Evaluation of Brain Atrophy in CIS Patients on Avonex
Condition: Multiple Sclerosis
9 Not yet recruiting Effect of Fingolimod on Neurodegeneration
Conditions: Cognition,;   Brain Volume Loss
Intervention: Drug: 0,5 mg Fingolimod
10 Recruiting Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition
Condition: Cognitive Decline
11 Active, not recruiting Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
Conditions: Autoimmune Diseases of the Nervous System;   Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis;   Disease Progression;   Brain Atrophy
Interventions: Biological: Tcelna;   Biological: Placebo
12 Recruiting Tau Imaging in Young Onset Dementia
Conditions: Alzheimer's Disease, Early Onset;   Logopenic Progressive Aphasia;   Posterior Cortical Atrophy (PCA)
Intervention: Drug: [18F]-T807 imaging tracer
13 Completed Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: Simvastatin;   Drug: Placebo
14 Unknown  Gait and Alzheimer Interaction Tracking (GAIT) Study
Conditions: Gait Apraxia;   Alzheimer Disease;   Impaired Cognition;   Cerebral Atrophy
15 Not yet recruiting A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis
Conditions: Relapsing Remitting Multiple Sclerosis;   Primary Progressive Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis
Interventions: Drug: testosterone;   Drug: placebo gel
16 Completed Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms
Condition: Multiple Sclerosis
Interventions: Drug: Fingolimod;   Drug: Interferon beta 1b
17 Not yet recruiting Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: 95% Pure ECGC capsules 200mg;   Drug: Placebo Comparator:
18 Unknown  A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Avonex and Topamax
19 Recruiting Telmisartan vs. Perindopril in Hypertensive Mild-Moderate Alzheimer's Disease Patients
Conditions: Alzheimer's Disease;   Hypertension
Interventions: Drug: Perindopril;   Drug: Telmisartan
20 Completed Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation
Conditions: Multiple Sclerosis;   Fatigue
Interventions: Drug: 3,4-diaminopyridine;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years